Directory
>
Paulo Falabella Md
Paulo Falabella Md
Vice President - Clinical Development & Operations, Patient Advocacy | Rare Diseases | REGENXBIO
Washington, District of Columbia, United States
Paulo Falabella Md
Summary
Paulo Falabella is a seasoned life sciences executive with a robust clinical and scientific background, specializing in advanced therapies and drug commercialization. He has played a pivotal role in the development and launch of groundbreaking gene therapies, notably LUXTURNA, the first FDA-approved gene therapy for a genetic disease in the U.S. His extensive experience spans multiple therapeutic areas, including CNS and ocular disorders, showcasing his versatility in the biotech landscape. Paulo has held significant leadership positions in reputable organizations such as REGENXBIO and Spark Therapeutics, where he has driven clinical development and patient advocacy initiatives. His academic credentials include a PhD in Cell-Based Therapies and an MBA from Harvard Business School, underscoring his commitment to merging scientific innovation with strategic business acumen. Paulo's passion for ophthalmology and regenerative medicine positions him at the forefront of transformative healthcare solutions.
Paulo Falabella Md
Work Experience
Vice President - Clinical Development & Operations, Patient Advocacy | Rare Diseases at
REGENXBIO
February 2019 - Present
VP, Medical Strategy Lead - Ophthalmology | Rare Diseases at
Spark Therapeutics, Inc.
January 2018 - January 2019
Global Medical Director, Ophthalmology | Rare Diseases at
Spark Therapeutics, Inc.
January 2015 - October 2018
Biotechnology/Pharmaceutical Consultant at
GRACE PHARMA MEDICAL STORE
January 2013 - January 2015
Medical | Surgical Retina Specialist at
Lambert Oftalmologistas
February 2011 - January 2013
Assistant Professor of Ophthalmology - Retina | Cataract at
Cvintal Oftalmologia
January 2010 - January 2013
Coordinator of Ophthalmology Department at
Cvintal Oftalmologia
January 2011 - January 2012
Paulo Falabella Md
Education
HBX | Harvard Business School, Core - Credential Of Readiness
January 2018 - January 2018
Universidade Federal de São Paulo, Phd - Cell-Based Therapies And Artificial Vision (Retinal Electrical Stimulation)
January 2013 - January 2018
University of Southern California, Postdoctoral Research Associate
January 2013 - January 2015
Universidade Federal de São Paulo, Ocular Bioengineering Fellowship
Instituto de Oftalmologia Tadeu Cvintal, Clinical And Surgical Fellowship In Vitreoretinal Diseases
Instituto de Oftalmologia Tadeu Cvintal, Ophthalmology Residency
Federal University of Juiz de Fora, Doctor Of Medicine (M.D.)
Frequently Asked Questions about Paulo Falabella Md
What is Paulo Falabella Md email address?
Paulo Falabella Md's primary email address is ****************@fb.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Paulo Falabella Md work for?
Paulo Falabella Md is a Vice President - Clinical Development & Operations, Patient Advocacy | Rare Diseases at REGENXBIO, a company specializing in Commercial physical research.
Where Paulo Falabella Md graduated from?
Paulo Falabella Md holds a degree in Business Administration And Management, General from HBX | Harvard Business School.
How can I directly contact Paulo Falabella Md?
To contact Paulo Falabella Md directly, you can use the email address ****************@fb.com. Complete contact information is available upon registration with Muraena.
Who is Paulo Falabella Md?
Paulo Falabella is a seasoned life sciences executive with a robust clinical and scientific background, specializing in advanced therapies and drug commercialization. He has played a pivotal role in the development and launch of groundbreaking gene therapies, notably LUXTURNA, the first FDA-approved gene therapy for a genetic disease in the U.S. His extensive experience spans multiple therapeutic areas, including CNS and ocular disorders, showcasing his versatility in the biotech landscape. Paulo has held significant leadership positions in reputable organizations such as REGENXBIO and Spark Therapeutics, where he has driven clinical development and patient advocacy initiatives. His academic credentials include a PhD in Cell-Based Therapies and an MBA from Harvard Business School, underscoring his commitment to merging scientific innovation with strategic business acumen. Paulo's passion for ophthalmology and regenerative medicine positions him at the forefront of transformative healthcare solutions.
Paulo`s contact details
****************@fb.com
**********@regenxbio.com
Colleagues
Chief Medical Officer
Executive Director, Global Product and Market Planning
Executive Director Drug Delivery & Training
Sr Vice President, Quality
Senior Vice President, Global Program Management & Alliance Management
Vice President, Medical Affairs
Vice President, Ophthalmology Clinical Development
Chief Communications & People Officer
VP, Nonclinical Development
Executive Director Clinical Operations